Literature DB >> 21099311

Expression of fatty acid binding proteins 3 and 5 genes in rat pancreatic islets and INS-1E cells: regulation by fatty acids and glucose.

Ayman Hyder1, Marwa Zenhom, Maja Klapper, Julia Herrmann, Jürgen Schrezenmeir.   

Abstract

Fatty acids binding proteins (FABPs) are involved in uptake, binding, transport and metabolism of fatty acids (FAs). Although FAs are known to stimulate insulin secretion from pancreatic islets when transiently elevated, while contributing to islet loss of function, lipotoxicity and apoptosis when chronically elevated, almost nothing is known regarding the FABPs in this tissue. The present study aimed at exploring the expression pattern and regulation of FABPs in rat islets and the insulin-secreting INS-1E cells. Rat islets and INS-1E cells expressed the heart/muscle type (FABP3) and the epidermal type (FABP5) genes. Different FAs significantly enhanced the expression of both FABPs. High glucose concentration induced a similar elevation of both FABP mRNA levels, and similarly to its effect on insulin 1 mRNA. Addition of oleic or palmitic acids to glucose did not render a further effect. FABP3 gene expression increased in response to PPARα agonist, while FABP5 increased in response to PPARα and PPARγ agonists, and decreased in response to a PPARβ agonist. Beta-oxidation of FAs is required for the gene expression of both FABP genes in INS-1E cells. Inhibition of CPT-1 by etomoxir inhibited the oleic acid-induced FABP 3 and 5 gene expression, while activation of AMPK by metformin amplified the oleic-induced expression of both FABPs. FABP3 and 5 gene transcription required de novo protein synthesis, since inhibition by cycloheximide significantly decreased both FABP mRNAs. These data show a complex interrelationship between glucose and FAs in the control of FABP gene expression and that FABP3 and 5 may play a role in insulin secretion.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21099311     DOI: 10.4161/isl.2.3.11454

Source DB:  PubMed          Journal:  Islets        ISSN: 1938-2014            Impact factor:   2.694


  6 in total

1.  Thymoquinone, a bioactive component of Nigella sativa, normalizes insulin secretion from pancreatic β-cells under glucose overload via regulation of malonyl-CoA.

Authors:  Joshua P Gray; Delaine Zayasbazan Burgos; Tao Yuan; Navindra Seeram; Rebecca Rebar; Rebecca Follmer; Emma A Heart
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-01-19       Impact factor: 4.310

2.  Association of increased plasma adipocyte fatty acid-binding protein with coronary artery disease in non-elderly men.

Authors:  Masayuki Doi; Toru Miyoshi; Satoshi Hirohata; Kazufumi Nakamura; Shinichi Usui; Ko Takeda; Mutsumi Iwamoto; Shozo Kusachi; Kengo Kusano; Hiroshi Ito
Journal:  Cardiovasc Diabetol       Date:  2011-05-23       Impact factor: 9.951

3.  Epidermal fatty acid-binding protein protects nerve growth factor-differentiated PC12 cells from lipotoxic injury.

Authors:  Jo-Wen Liu; Manuel Montero; Liming Bu; Marino De Leon
Journal:  J Neurochem       Date:  2014-09-19       Impact factor: 5.372

4.  E2F8 promotes hepatic steatosis through FABP3 expression in diet-induced obesity in zebrafish.

Authors:  Yasuhito Shimada; Shisei Kuninaga; Michiko Ariyoshi; Beibei Zhang; Yasuhiko Shiina; Yoshinori Takahashi; Noriko Umemoto; Yuhei Nishimura; Hiroyuki Enari; Toshio Tanaka
Journal:  Nutr Metab (Lond)       Date:  2015-05-20       Impact factor: 4.169

Review 5.  The Biological Functions and Regulatory Mechanisms of Fatty Acid Binding Protein 5 in Various Diseases.

Authors:  Binyue Xu; Lu Chen; Yu Zhan; Karl Nelson S Marquez; Lvjia Zhuo; Shasha Qi; Jinyu Zhu; Ying He; Xudong Chen; Hao Zhang; Yingying Shen; Gongxing Chen; Jianzhong Gu; Yong Guo; Shuiping Liu; Tian Xie
Journal:  Front Cell Dev Biol       Date:  2022-04-04

6.  Fatty-acid-induced FABP5/HIF-1 reprograms lipid metabolism and enhances the proliferation of liver cancer cells.

Authors:  Jieun Seo; Do-Won Jeong; Jong-Wan Park; Kwang-Woong Lee; Junji Fukuda; Yang-Sook Chun
Journal:  Commun Biol       Date:  2020-10-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.